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A paternal-age effect and the exclusive paternal origin of mutations have been reported in Apert syndrome (AS). As
the incidence of sporadic AS births increases exponentially with paternal age, we hypothesized that the frequency
of AS mutations in sperm would also increase. To determine the frequency of two common FGFR2 mutations in
AS, we developed allele-speciﬁc peptide nucleic acid–PCR assays. Analyzing sperm DNA from 148 men, age 21–
80 years, we showed that the number of sperm with mutations increased in the oldest age groups among men who
did not have a child with AS. These older men were also more likely to have both mutations in their sperm.
However, this age-related increase in mutation frequency was not sufﬁcient to explain the AS-birth frequency. In
contrast, the mutation frequency observed in men who were younger and had children with AS was signiﬁcantly
greater. In addition, our data suggest selection for sperm with speciﬁc mutations. Therefore, contributing factors
to the paternal-age effect may include selection and a higher number of mutant sperm in a subset of men ascertained
because they had a child with AS. No age-related increase in the frequency of these mutations was observed
in leukocytes. Selection and/or quality-control mechanisms, including DNA repair and apoptosis, may contribute
to the cell-type differences in mutation frequency.
Much has been written about the “mutagenic male”
(Hurst and Ellegren 2002) and the higher male-to-female
mutation rate in many genetic disorders (Vogel and Rath-
enberg 1975; Crow 2000). Conventional wisdom says
that the greater number of germ-cell divisions in males
compared with females contributes to the highermutation
frequency in males (Penrose 1955), which manifests as an
increased incidence with paternal age of de novo cases of
disorders, as well as paternally derived mutations (Mo-
loney et al. 1996; Shuffenecker et al. 1997; Wilkin et al.
1998; Glaser et al. 2000). However, the linear increase
with age in the number of divisions does not fully explain
the exponential increase with paternal age in the incidence
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of affected children (Vogel and Rathenberg 1975; Risch
et al. 1987; Crow 2000). The increased incidence with
paternal age of affected children should reﬂect a corre-
sponding increase with age in the frequency of mutations
in sperm.
To test this hypothesis, we used Apert syndrome (AS)
as a model. AS (MIM 101200) is characterized by cranio-
synostosis and syndactyly of the hands and feet and oc-
curs in 1/65,000 to 1/160,000 live births (Blank 1960;
Cohen et al. 1992). Of all sporadic cases, 199% are
caused by one of two mutations in the ﬁbroblast growth-
factor receptor 2 (FGFR2) gene, 755CrG or 758CrG.
The 755CrG mutation occurs in a CpG dinucleotide,
whereas the 758CrG mutation does not. This difference
may explain the higher mutation rate ( vs.65# 10
) and incidence of children with AS (67% vs.62.7# 10
32%)with the former base-pair change (Park et al. 1995;
Wilkie et al. 1995).
One hundred forty-eight men participated in this study
from two independent study sites, which served as rep-
licate samples. Fifty-seven were recruited from the greater
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Baltimore area (Johns Hopkins Hospital [JHH]), (mean
age 42.0 years, range 21–78 years), and 76 were acquired
from the Lawrence Livermore National Laboratories
(LLNL) (mean age 43.0 years, range 22–80 years) in
Livermore, CA, as part of the University of California at
Berkeley and the LLNL Age and Genetic Effects on Sperm
(AGES) study (Eskenazi et al. 2003). These 133 men did
not have children with AS (referred to herein as “con-
trols”). Each of 15 unaffected men who had a child with
AS was recruited from online support groups or through
his child’s physician in the United States (mean age 44.1
years, range 34–64 years). There were no statistical dif-
ferences by two-tailed Student’s t tests between the av-
erage ages of the JHH and AGES controls ( ) andP 1 .6
between all 133 controls and the 15 fathers ( ). OfP 1 .6
the 15 men who had children with AS, 6 had a child with
the 755CrG mutation, whereas 1 had a child with the
758CrGmutation. None of the other eight men provided
information about his child’s mutation. Semen samples
from JHH participants were received within a 24-h pe-
riod and immediately aliquoted and stored frozen until
DNA was isolated. Second semen samples, obtained at
least 3 mo after the ﬁrst samples, were provided by 35/57
JHH controls and 2/15 fathers. Blood samples were also
obtained from 21/57 JHH controls but from none of the
fathers of children with AS. Sample collection for the
AGES study was similar, except that the samples were
collected and processed within 2 h. Participants in both
the JHH and AGES studies completed an epidemiologi-
cal questionnaire. Subjects were excluded if they had a
semen analysis with zero sperm count, a vasectomy, or
a history of cancer; had received chemotherapy or ra-
diation therapy for cancer; had smoked cigarettes in the
last 6 mo; or had a fever 1101F in the last 3 mo (Es-
kenazi et al. 2003). Informed consent was obtained from
men in both sample sets after approval was given by the
appropriate institutional review board.
DNA was isolated from sperm and whole blood, ac-
cording to PUREGENE protocols 00900 and 00050, re-
spectively. To ensure the lysis and removal of all nonsperm
cells, an additional incubation step, with Cell Lysis so-
lution followed by centrifugation, was added. DNA iso-
lations were performed one at a time in an isolated PCR
hood that was UV irradiated for at least 20 min between
samples.
The two recurrent mutations in AS, 755CrG and
758CrG,were detected using one-step allele-speciﬁcPCR
assays. The speciﬁcity of these assays depended on a pep-
tide nucleic acid (PNA) that masked the wild-type allele
and allowed ampliﬁcation from only the mutant allele
(Orum et al. 1993). All PNA-PCR reactions were per-
formed on the Roche LightCycler with the FastStart DNA
Master SYBR Green I kit (Roche Molecular Biochemi-
cals). Reactions were performed in a 20-ml volume with
150 ng DNA, equivalent to 50,000 sperm, and a ﬁnal
concentration of 0.5 mM of each primer, 2 mM PNA
5′-GATCGCCTCACCG-3′, and either 4 mM (for the
755CrG mutation) or 3.5 mM (for the 758CrG mu-
tation)MgCl2. Samples were analyzed 7–16 times, equiva-
lent to 350,000–800,000 sperm, for each mutation. This
number of trials allowed for a 190% chance of detection
of one mutant sperm, assuming the incidence of mutant
sperm would be similar to the birth incidence of AS. The
reproducibility of the assays was ascertained by deter-
mining concordance between duplicate semen samples
and between the JHH and AGES samples sets. Little ev-
idence for a difference in either comparison was found
( and , respectively).Pp .09 Pp .085
For the 755CrG mutation, primers 5′-TAGATTCAG-
AAAGTCCTCACC-3′ and 5′-CCTCTCTCCACCAGA-
GCGTTG-3′ were used to amplify a 224-bp product. PCR
cycle conditions were: 10 min at 94C, followed by 45
cycles of 15 s at 94C, 5 s at 70C, 5 s at 69C, and 12
s at 72C. For the 758CrG mutation, primers 5′-TAGA-
TTCAGAAAGTCCTCACC-3′ and 5′-TCCACCAGAG-
CGATCGCG-3′ were used to amplify a 218-bp product.
PCR cycle conditions were: 10 min at 94C, followed by
40 cycles of 15 s at 94C, 5 s at 70C, 5 s at 66C, and
12 s at 72C. The primers that ampliﬁed the 755CrG
mutation did not amplify the 758CrG mutations and
vice versa (ﬁg. 1a). Melt-curve analysis was performed
immediately after ampliﬁcation in every experiment to
determine the presence of the speciﬁc product. Samples
were analyzed by gel electrophoresis to conﬁrm that the
single peak observed in the melt-curve analysis corre-
sponded to a band of the correct size (data not shown).
PCR products were then sequenced to conﬁrm ampli-
ﬁcation from only the mutant allele (data not shown).
Standard curves were constructed for the 755CrG and
the 758CrG mutations by diluting genomic DNA from
an affected patient heterozygous for each mutation with
human genomic DNA (Roche Molecular Biochemicals).
The standards used in each experiment were 45, 15, 5,
and 1 mutant copies in human genomic DNA. The num-
ber of mutant sperm per 50,000 was determined from
the standard curve. If the cycle threshold of a sample was
greater than that of the last standard and the melt-curve
analysis showed the presence of mutant sperm, we as-
signed a value of 1 mutant sperm in 50,000 to this sam-
ple, the lowest possible biological value in our assay (ﬁg.
1b and 1c). One copy of the mutation in a background
of 50,000 wild-type copies, or haploid sperm, repeatedly
ampliﬁed and showed a speciﬁc peak on the melt-curve
analysis, whereas negative controls, wild-type human ge-
nomic DNA, and water did not (ﬁg. 1b–d). The assays
were not accurate with fewer than 1/50,000 mutant
sperm.
Among 133 men who did not have a child with AS,
the frequency of sperm with either mutation increased
with age (ﬁg. 2a and 2b). To assess the statistical signiﬁ-
Figure 2 Mutation frequency with age. The number of spermwith either FGFR2mutation increases with age. a,Average for a given individual.
A single diamond symbol may represent more than one individual with the same age and mutation frequency. b, Average for a given decade.
Error bars indicate the 95% CIs. c, Percent of men in each age group with both mutations in sperm increases with age. Above each bar is the
number of men with both sperm mutations over the total number of men in each age group. Insets are for each mutation or either mutation,
as noted. Circles in panel a indicate those individuals who had both mutations in their sperm.
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Figure 3 Comparison between the sperm mutation frequency (data from ﬁg. 2a) and frequency of birth of children with AS (Risch et al.
1987), by use of fold change with respect to the value for age !25 years.
cance of this observation, we used a generalized linear
model (McCullagh and Nelder 1989), with the assump-
tion that the number of mutant copies in a sperm sample
was Poisson distributed with mean increasing exponen-
tially with age, and we performed a permutation test
(Manly 1997) with 1,000 permutation replicates. All sta-
tistical analyses were performed with the software R, ver-
sion 1.7.0 (Ihaka and Gentleman 1996). This analysis
showed signiﬁcant evidence for an increase with age in
mutation frequency in these control individuals (Pp
). An age-related increase in the mutation frequency.008
was also observed when the two individual mutations
were considered separately ( for 755CrG;Pp .025
for 758CrG). This increase, along with anPp .008
increase in variability in mutation frequencies among
individuals in a given decade, was greatest in men aged
160 years (ﬁg. 2b). Sperm from men aged 170 years were
more likely to have both the 755CrG and 758CrG
mutations (20–29 years vs. 70–80 years; ;Pp .013
Fisher’s exact test; ﬁg. 2a and 2c), suggesting that DNA-
repair mechanisms may decrease in efﬁciency with age.
In support of this hypothesis, recent studies have shown
downregulation and decreased activity of several DNA-
repair proteins in sperm from older mice and rats (Vani
and Rao 1997; Intano et al. 2002).
Having demonstrated that the frequency of AS muta-
tions in sperm increases in the oldest age groups, we
wanted to compare these results with data on de novo
cases of AS. To do so, we determined if the distribution
of paternal ages for AS births (Risch et al. 1987) was
similar to that which would be expected, given the ob-
served mutation frequencies in sperm.We considered the
seven age groups 19–24, 25–29, 30–34, 35–39, 40–44,
45–49, and 50–59 years and assumed that the mutation
frequency in a sperm sample for a subject in an age group
A was Poisson distributed with mean lA. The data on
paternal ages from Risch et al. (1987) were assumed to
follow a multinomial distribution, with qA denoting the
probability that the father of a child with AS is in age
group A. Let pA denote the proportion of fathers who
are in age group A, taken from census data cited in Risch
et al. (1987) and assumed to be known without error.
By Bayes’s rule, the age-speciﬁc mutation frequencies in
sperm, lA, imply that the expected proportion of fathers
of children with AS who are in age group A would be
. We tested the hypothesis that, for all agel p /Sl pA A A A
groups, , by a likelihood-ratio test. Sta-q p l p /Sl pA A A A A
tistical signiﬁcance was assessed via a parametric boot-
strap, with 1,000 bootstrap replicates. We found that the
increased frequency of mutant sperm in the oldest age
groups is in contrast with the exponential increase in AS-
birth frequency, which begins at age ∼37 years (Pp
; ﬁg. 3) (Risch et al. 1987). These results are consis-.001
tent with those from a previous study of sporadic achon-
944 Am. J. Hum. Genet. 73:939–947, 2003
Figure 4 Comparison of the mutation frequencies in men who have and have not fathered a child with AS. The inset shows the comparison
between men with a child with AS and all men, whether or not they had fathered a child.
droplasia (MIM 100800), which show a discrepancy be-
tween the frequency of the FGFR3 1138GrA mutation
in sperm and at birth (Tiemann-Boege et al. 2002). This
indicates that the paternal-age effects in both AS and
achondroplasia are not entirely due to the increased fre-
quency with age of mutations in sperm.
The above data were based onmen in the general popu-
lation who had not fathered a child with AS and ex-
cluded any men who had a child with AS. To test the
hypothesis that these groups of men may differ in their
mutation frequencies, sperm DNA from men who had
children with AS were analyzed for both FGFR2 mu-
tations. We found that these 15 men had signiﬁcantly
greater mutation frequencies at an earlier age, compared
with men who had fathered unaffected children (np
; ) or to all men, whether or not they had69 Pp .002
children ( ; )(ﬁg. 4). These P valuesnp 133 Pp .001
were obtained by a permutation test using the general-
ized linear model described above, with group-speciﬁc
slopes and intercepts. The observed mutation frequency
in sperm from men who had children with AS appears
to approximate the birth frequency of AS more closely
than the mutation frequency from control men. Of the
10 men aged !45 years who had children with AS, 3 had
mutation frequencies (∼1/50,000mutant sperm) thatwere
similar to those in 5/23 60–80-year-old control men. This
percentage (30%; 3/10) of fathers of children with AS is
signiﬁcantly different, compared with the percentage of
control men (2.4%, 2/85) age !45 years who had similar
mutation frequencies ( , Fisher’s exact test).Pp .008
The overall estimated mutation frequency, averaged
across all ages, was 11 per 1 million sperm (95% CI 3–
19 per 1 million) in fathers who had a child with AS
and 3.9 per 1 million sperm (95% CI 2.9–5.2 per 1
million) in men who did not have a child with AS, con-
sistent with the former group having a higher occurrence
of mutant FGFR2 sperm or level of mosaicism. This
higher level of mosaicism among younger men who had
fathered a child with AS has implications for genetic
counseling, as it would increase their risk of having an-
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Figure 5 Comparison of the mutation frequencies in sperm and white blood cells from the same individual in a subset of 21 men who
did not have a child with AS.
other affected child. This observation could result from
bias of ascertainment or earlier mutational events, pos-
sibly owing to an increased susceptibility to mutations,
in fathers of a child with AS. Although we excluded
anyone who had obvious exposure to mutagens, such
as radiation therapy or chemotherapy, there may be
other more subtle environmental factors that we are un-
aware of at this time that could inﬂuence mutation rate.
It is possible that the risk of fathering a child with AS
may increase even more as themen become older, because
these mutational events, presumably occurring in the
spermatogonial stem cells, would accumulate with age.
However, we could not determine how the mutation fre-
quency increased with age amongmen who have children
with AS, as there were only three fathers aged 150 years
in this group.
To test the hypothesis that the increase with age in
mutation frequency in sperm corresponds to an increase
in somatic cells, we analyzed for both mutations in blood
samples from men in this study. No increase with age in
mutation frequency, in particular in men aged 160 years,
was observed in white blood cells ( ), a resultPp .71
that is signiﬁcantly different from that observed in sperm
( ; paired permutation test) (ﬁg. 5). AS muta-Pp .001
tions may not accumulate with age in white blood cells
as they do in sperm, even though both arise from con-
stantly regenerating stem cells, because of cell-type spe-
ciﬁc selection (Murdock et al. 2000).
Differences between the two mutations may also play
a role in selection. These gain-of-function mutations, al-
though occurring in adjacent amino acids, result in dif-
fering ligand afﬁnities and speciﬁcities of the mutant ty-
rosine-kinase receptors (Yu et al. 2000; Ibrahimi et al.
2001). Although the 755CrG mutation accounts for
twice as many cases of AS as does the 758CrG muta-
tion, each is present at approximately the same frequency
in sperm (1/500,000), which suggests either that the
755CrG mutation confers a selective advantage to
sperm or that the 758CrG mutation is selected against
in sperm or in utero. The 755CrG mutation, which
occurs in a CpG dinucleotide, is notable because CrT
or GrA transitions tend to occur more often than trans-
versions in this context. The fact that the less-common
transversion is observed more often at this base suggests
selection for this speciﬁc nucleotide change.
In conclusion, our study suggests that there are many
contributing factors to the paternal-age effect in AS. It
cannot be explained solely by the increase in mutation
frequency in sperm, which occurs much later in life and
is not as exponential as the birth frequency. We found
that fathers of children with AS are a subgroup of men
in whom the increased frequency ofmutant spermoccurs
946 Am. J. Hum. Genet. 73:939–947, 2003
at an earlier age, which may contribute to the paternal-
age effect. Selection for sperm with mutations may be
another contributing factor, as suggested by our analy-
sis of two different mutations. These ﬁndings may extend
to other disorders with paternal-age effects, such as
achondroplasia, Crouzon (MIM 123500) and Pfeiffer
(MIM 101600) syndromes, and multiple endocrine neo-
plasia type 2A (MEN2A [MIM 171400]), but further
study is needed. We also show that increases with age in
mutation frequency and number of different mutations
are not observed in white blood cells, which suggests that
age effects are cell-type speciﬁc. Accumulated environ-
mental exposure, reduced efﬁciency of DNA-repairmech-
anisms or apoptosis, or altered physiological selection
during spermatogenesis may be involved in the differences
observed between mutation frequencies. In-depth genetic
and environmental studies may help to delineate sub-
groups of men at higher risk for having affected children.
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